BLEOMYCIN-CO-57 SCANNING OF HILA AND MEDIASTINUM IN PATIENTS WITH BRONCHIAL-CARCINOMA - PROSPECTIVE-STUDY
BLEOMYCIN-CO-57 SCANNING OF HILA AND MEDIASTINUM IN PATIENTS WITH BRONCHIAL-CARCINOMA - PROSPECTIVE-STUDY
复制标题
DOI：
10.1136/thx.31.6.641
复制
发表时间：
1976-01-01
期刊：
影响因子：
10
通讯作者：
WOLDRING, MG
中科院分区：
文献类型：
--
作者：
RASKER, JJ;BEEKHUIS, H;WOLDRING, MG
由于钴-57-博莱霉素（57Co-bleo）作为肺肿瘤患者的肿瘤寻找药物的结果是有希望的，因此我们进行了一项前瞻性研究，以测试该技术对支气管癌患者肺门和纵隔转移的敏感性和选择性。57Co-bleo显像的灵敏度高于常规放射检查和纵隔镜检查。因此，建议57Co-bleo显像可作为选择患者进行纵隔镜检查的一种方法。
Because the results with cobalt-57-bleomycin (57Co-bleo) as a tumour-seeking agent in patients with pulmonary tumours were promising, a prospective study was carried out to test the sensitivity and selectivity of this technique for metastases in lung hila and mediastinum in a group of patients with bronchial cancer. The sensitivity of 57Co-bleo scintigraphy appeared to be higher than that of routine radiological investigations and mediastinoscopy. For this reason it is suggested that 57Co-bleo scintigraphy can be used as a method to select patients for mediastinoscopy.